Northern Trust Corp Sells 37,203 Shares of Select Medical Holdings Corporation $SEM

Northern Trust Corp decreased its holdings in Select Medical Holdings Corporation (NYSE:SEMFree Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,314,843 shares of the health services provider’s stock after selling 37,203 shares during the period. Northern Trust Corp owned about 1.02% of Select Medical worth $21,958,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of SEM. Caitong International Asset Management Co. Ltd boosted its stake in shares of Select Medical by 61.6% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,703 shares of the health services provider’s stock worth $45,000 after buying an additional 1,030 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Select Medical by 217.4% in the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider’s stock worth $109,000 after buying an additional 4,453 shares during the last quarter. Lazard Asset Management LLC boosted its stake in shares of Select Medical by 47.8% in the 4th quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock worth $130,000 after buying an additional 2,255 shares during the last quarter. Wealthquest Corp purchased a new position in shares of Select Medical in the 1st quarter worth $143,000. Finally, Covestor Ltd boosted its stake in shares of Select Medical by 115.7% in the 1st quarter. Covestor Ltd now owns 10,690 shares of the health services provider’s stock worth $179,000 after buying an additional 5,735 shares during the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Price Performance

Shares of Select Medical stock opened at $13.03 on Monday. The stock’s 50-day simple moving average is $13.85 and its 200-day simple moving average is $15.48. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $40.98. The company has a market capitalization of $1.61 billion, a price-to-earnings ratio of 12.29, a PEG ratio of 0.53 and a beta of 1.25. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.92.

Select Medical (NYSE:SEMGet Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, beating the consensus estimate of $0.28 by $0.04. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The business had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the previous year, the business earned $0.60 earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, analysts expect that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Wednesday, August 13th. Select Medical’s payout ratio is presently 23.58%.

Wall Street Analyst Weigh In

SEM has been the topic of a number of research reports. Royal Bank Of Canada dropped their price target on Select Medical from $23.00 to $19.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 7th. UBS Group reiterated a “neutral” rating and set a $14.00 target price (down from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.

Check Out Our Latest Analysis on SEM

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading

Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Corporation (NYSE:SEMFree Report).

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.